|
SEATTLE (Nov. 24, 2020) - Codexis and existing Series A investor, Casdin Capital, have co-invested in Arzeda as part of the SynBio Innovation Accelerator. In addition to the capital investment, Codexis and Arzeda look forward to collaborate on areas of synergy and mutual advantage. Press release from Codexis and Casdin Capital available here.
1 Comment
Ken moss
11/25/2020 06:46:20 am
As a Cdxs investor and big fan it’s interesting to see a mini peer that CDXS thinks is going to be an asset as these 2 companies move forward. Interesting collaboration I think. These are Fene it’s? As CDXS is not normally an investor in companies but uses its excess talent or invests Le funds to develop its own potential pharmaceuticals. Azenda must have some powerful valuable knowledge that brought this about. This is not a normal course of business but I like it.
Reply
Leave a Reply. |